Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone | Director, Consumer Global Brand Protection.

Slides:



Advertisements
Similar presentations
Our role in the U.S. pharmaceutical supply chain:
Advertisements

الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.
Promoting patient-centred healthcare around the world Counterfeit Medicines: The views and role of patients and patients’ organizations Jeremiah Mwangi.
Alessandro de Luca Senior Vice President MERCK Group
Bringing the Voice of the Consumer Into Your Supply Chain Jake Barr Director, Consumer Driven Supply Network Global Mfg, Planning & Logistics The Procter.
Tom Kubic Executive Director Pharmaceutical Security Institute World Bank Washington 10 March 2005 The Spreading Plague of Counterfeiting.
Patents pending Uniquely Identifying Your Products and Consumers Nakul Pasricha, COO 23 rd July, 2014 PharmaSecure, New York 601 West 26th Street, Suite.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
U.S. Drug Supply Chain Integrity: Protecting Patient Safety CDR Connie Jung, PharmD, PhD LCDR Eleni Anagnostiadis, RPh Office of Drug Security, Integrity,
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford,
No /72, Level 2, Sri Balaji Mansion, Dr. Rajkumar Road, Rajajinagar 4th Block, Bangalore , India. Counterfeit Drug Detection | Fake Product.
- 0 - Medicines manufactured under these conditions What do you want your Patients to receive??
Counterfeit Medicines and Fight against Counterfeit Medicines.
PSM India Bejon Misra, Founder Director.
Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
SCHEDULING OF MEDICINES SAPRAA 13 June Scheduling of Medicines Ephedrine Pseudoephedrine D-nor-pseudoephedrine.
Peter Brudenall & Caroline Evans- Simmons & Simmons Marsh Technology Conference 2005 Zurich, Switzerland. Managing the Security Landscape – Legal and Risk.
1 Promoting Safe Medicine With Track and Trace Systems SRC Technologies, Inc.
Geneva, Switzerland, November 2014 United Arab Emirates Experience Ahmad Alshamsi Manager Type Approval, UAE TRA Combating.
© 2012 TeraMedica, Inc. Big Data: Challenges and Opportunities for Healthcare Joe Paxton Healthcare and Life Sciences Sales Leader.
Trends in Corporate Social Responsibility Reporting
Protecting Schools and Staff in a Volatile World: An Essential Guide to Safety and Risk Management Presenter: Ricardo Urbina.
Corporate Responsibility and Third Party Relationships GSK and Contract Manufacturers James Hagan Vice President Corporate Environment, Health & Safety.
Tackling the Illicit Trade – JTI’s Approach Sofia, June
WEC The Integration of HSE into Supply Chain Business Relationships WEC International Environment Forum London, UK October 2003 Tony Lloyd,
1 Supply Chain Security & Brand Protection AAFA Knock It Off Conference Long Beach, CA November 7, 2007.
Johnson & Johnson Overview Incorporated in 1887: Listed on NYSE in 1944 symbol JNJ 250 operating companies, 117K employees in 57 countries Three business.
Saving Lives, Saving Money Lilia Bounab – Healthcare Sales Manager EMEA Ar ł amów hotel, 14-16th June 2015.
Global Sourcing Perspectives from a small Danish company October 18 th, 2010.
Asly (Genuine) Global Forum Innovation and Technology Entrepreneurship East London, South Africa May, 2013.
Global Erythritol Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015.
The Pricing of Pharmaceuticals facing Grey Imports Toulouse, December 2003 Claude Crampes - Abraham Hollander.
The Impact of Privacy on HP’s Customer Relationship Management Solution Mike Overly Vice President, Marketing © 2003 Hewlett-Packard Development Company,
1 Good Intentions – Bad Drugs Washington, DC Thursday, 10 March 2005 Robert D. Moore, Executive Director; Global Security Group Merck & Co., Inc.
The Tobacco Institute of Southern Africa ILLICIT TRADE IN CIGARETTES 25 March 2015 COMESA BUSINESS COUNCIL 25 March 2015 COMESA BUSINESS COUNCIL.
The Supply Chain Index The Supply Chain Index and
SCOR® Risk Management Team Update
Responsible Care® Awareness for Managers 1. DISCUSSION POINTS 2 WHAT IS RESPONSIBLE CARE®? FEATURES OF RESPONSIBLE CARE® HOW DOES RESPONSIBLE CARE® ADD.
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
FFIEC Cyber Security Assessment Tool
China Bottled Mineral Water Market
A global nonprofit: Focusing on IP Protection and Anti-Corruption Sharing leading practices based on insights from global companies, academics, organizations.
By: Drew Perry. Counterfeit pharmaceutical drugs are fraudulently produced or mislabeled medicines purchased by consumers who believe them to be legitimate.
Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
“Addressing evolving supply chain challenges to improve performance” David Brown Head of Supply Chain & Operations EY Ireland Please see final slide for.
Counterfeiting Protection & Reduction MECH 3620 Advanced Manufacturing Process By: Rafael Mendez.
Supply Chain Insights LLC Copyright © 2015, p. 1 Supply Chain Risk Management Study Summary Charts July 2015.
MarketsandMarkets Presents Hospital/Pharmaceutical Asset Management Market worth $6.7 Billion By 2017
© 2014 GS1 US ALL RIGHTS RESERVED Making a Difference 1.
Custom healthcare packaging solutions
CREATING THE TRUSTED SUPPLY CHAIN
Physical Security Governance Model
Bringing an innovative product to market: Assure®
Preventative Measures
Location Analytics Market Expected To Reach $11.84 Billion by 2019
SAMAC Marketing Strategy
Smarter, safer Pharmaceuticals
Global Cyber Insurance Market By Manufacturers, Countries, Type And Application, Forecast To 2022 Publish Date : 04-Dec-2017 No of Pages : 116 Single User.
American Society for Quality Region 5 Quality Conference
National Pharmacy Practice Standards the Regulatory Role
MANUFACTURER SURVEY GIRP-IPF STUDY 2016.
Quality and Accreditation in Health care setting
New Zealand Testing and Compliance for Standards and Labelling
Stallion Systems & Solution Pvt Ltd
Counterfeiting and Intellectual property theft in Medicines World Bank Symposium March 10, 2005 Washington DC Frederick Razzaghi Director of Technical.
Adroit Market Research +1 (214) Single Use License: US$ 4800 Request Sample Global.
Presentation transcript:

Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone | Director, Consumer Global Brand Protection

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 2 Create active collaboration group MFGs & Retailers: Help protect consumers & patients o Counterfeiting & diversion is serious and growing Support Branding & Consumer Confidence o Manufacture & Retailer Support Business Growth o Alignment with business strategies Objective:

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 3 What’s a counterfeit? Fake product in a fake package? Fake product in a genuine package? The real product repackaged in a real or fake package? The real product repackaged to extend a shelf life? The real product from a different country repackaged? Yes! All / Any of the above

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 4 Counterfeiting Apparel, DVDs, watches... money, cigarettes... But …. Healthcare???  Pharmaceuticals?  Medical Devices?  Consumer Products? Shampoo?, Soap?,... Really?

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 5 Counterfeiting is a large and growing business The World Health Organization (WHO) states that worldwide sales of counterfeit medicines could top $75 billion, a 90% increase in five years 30% of certain drugs consumed in developing countries are counterfeit In Africa estimates are that 50% of the anti-malarias and HIV drugs are counterfeit The Threat is Real....

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 6 Counterfeiting – an issue primarily outside US... RIGHT? Estimates for US: 1% of pharmaceuticals are counterfeit 5% of Consumer products and Medical Devices imported into the United States are counterfeit

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 7 If you’re a category leader, you’re a target for counterfeiting In the last 5 years: –We have identified counterfeit products in every major category –We have identified counterfeit products in every region of the world –We have identified counterfeits in every channel of sale Counterfeiting is a problem for consumer goods and the healthcare industry in general!

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 8

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 9 Diversion – Not Just a Business Issue Diversion may result in mishandling or contamination of products Diversion enables counterfeiters Diversion is how counterfeits are inserted into legitimate channels

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 10 Why Global Brand Protection (GBP)? Patient Safety Reputation of the product Reputation of the brand Reputation of the manufacturer & Retailer Legal liability  Centralized Brand Protection function consists of Global Sector Leads for strategy and regional coverage  Regional (cross-sector) Leads for emerging markets  Central support for anti- counterfeiting (ACF) technology and programs

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 11 Safe & Secure Supply Chain 1.Incident Reporting and Management 2.Awareness and Education 3.Market Monitoring 4.Commercial Insights 5.Distributor Compliance 6.External Manufacturer 7.Product Protection 8.Product Returns and Destruction 9.Transportation Security 10.Facility Security

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 12 1.Incident Reporting and Management 2.Market Monitoring 3.Commercial Insights Prompt reporting and management is critical to protect our patients Monitoring can identify issues before a product is dispensed to patients Internally available commercial data can guide our monitoring efforts and help investigate incidents Safe & Secure Supply Chain Practices

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 13 4.Awareness and Education 5.Distributor Compliance 6.External Manufacturer Awareness and Education can further our efforts by involving all associates and business partners Contractual language and proper due diligence can create a safer supply chain Implementation of measures to mitigate the inherent risks associated with using an external partner in a global supply chain Safe & Secure Supply Chain Practices

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 14 7.Product Protection 8.Product Returns and Destruction Risk-based assessments for new products Technology is applied based on level and type of risk Not serialization! Eliminate possibility of counterfeit product being restocked and sold Reduce possibility that product meant for destruction ends up in the grey market Safe & Secure Supply Chain Practices

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 15 9.Transportation Security 10.Facility Security Proper transportation security can reduce theft and pilferage, reducing source of product for grey market Facility security is vital for both finished goods and for WIP and packaging materials Safe & Secure Supply Chain Practices

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 16 Need to create active collaboration group: Protect consumers & patients o Counterfeiting & diversion is serious and growing Preserve Branding & Enhance Consumer Confidence o Manufacture & Retailer Support Business Growth o Alignment with business strategies Summary:

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential | 17 Thank You! For more information, please contact Jim Mentone (908)